Back to search

University of British Columbia

Treatment of obesity and diabetes by a regulatable leptin cell therapy system

Abstract

dc:description

Obesity, a chronic disorder that is increasing in prevalence worldwide, is a major risk factor for the development of type 2 diabetes, a metabolic disorder characterized by hyperglycemia. In this thesis, the efficacy of a leptin cell therapy was evaluated for the treatment of obesity and diabetes in leptin-deficient ob/ob mice and in high fat fed, leptin-resistant C57BL/6J mice. A gut endocrine K-cell line was engineered to produce leptin under the regulation of an RU486 controlled GeneSwitch™ system. In culture, these cells express and release leptin in an RU486 dose- and time-dependent manner. These cells were transplanted into ob/ob mice via (a) kidney capsule and (b) intraperitoneal (IP) injection of alginate encapsulated cells along with 14-day RU486 pellets. In mice that received leptin-producing cells under the kidney capsule, reductions in body weight (10%), food intake (50%) and blood glucose levels (67%) were observed 10 days post-transpjant, relative to controls. Body weight and food intake rapidly increased thereafter to that of controls. Interestingly, however, blood glucose concentrations remained reduced by 40% up to 2 weeks post-transplantation. Animals given IP encapsulated cells lost up to 17% of body weight and then rapidly returned to their starting weight 14 days later at exhaustion of the RU486. Remarkably, despite the fact that body weight was completely regained within 20 days posttransplantation, blood glucose concentrations remained reduced by almost 70% up to 50 days post-transplantation. Both the number of transplanted cells and the dose of RU486 given could regulate the effects of leptin cell therapy. Obese C57BL/6J mice on a high fat diet did not respond with reductions in body weight, food intake or blood glucose levels after being transplanted with encapsulated leptin-producing gut cells. These data demonstrate that leptin administered via a cell therapy strategy can result in a reduction in body weight, food intake and long term corrections of blood glucose concentrations in leptin sensitive ob/ob mice but not in high fat fed leptin resistant C57BL/6J mice under the conditions tested.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Physiology
Grantor dc:publisher
University of British Columbia
Year dc:date
2005

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Oosman, Sarah Natasha

Rights

dc:rights
Statement dc:rights
  • For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/16652

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Oosman, Sarah Natasha. Treatment of obesity and diabetes by a regulatable leptin cell therapy system. master's thesis, University of British Columbia, 2005. http://hdl.handle.net/2429/16652